SENSEX NIFTY
Apollo Hospitals Enterprises Directors Report, Apollo Hospital Reports by Directors
YOU ARE HERE > MONEYCONTROL > MARKETS > HOSPITALS & MEDICAL SERVICES > DIRECTORS REPORT - Apollo Hospitals Enterprises
Apollo Hospitals Enterprises
BSE: 508869|NSE: APOLLOHOSP|ISIN: INE437A01024|SECTOR: Hospitals & Medical Services
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Jul 30, 17:00
1326.05
0.5 (0.04%)
VOLUME 4,823
LIVE
NSE
Jul 30, 17:00
1328.25
3.75 (0.28%)
VOLUME 172,360
Download Annual Report PDF Format 2014 | 2013 | 2012 | 2011
Directors Report Year End : Mar '15    « Mar 14
 Dear Members,
 
 The Directors are pleased to present the THIRTY FOURTH ANNUAL REPORT
 and the audited statements of accounts for the year ended 31st March
 2015.
 
 Financial Results (Standalone)
 
                                                       (Rs.  in million)
 
 For the year ended                      March 31,2015     March 31,2014
 
 
 Income from operations                         45,928            38,616
 
 Profit before Exceptional Items                 4,820             4,201
 and Taxation
 
 Provision for Taxation                          1,207               894
 
 Net Profit before Exceptional Item              3,613             3,307
 after Taxation
 
 Exceptional Item                                (147)                 -
 
 Net Profit after Exceptional Item               3,466             3,307
 
 Balance of Profit brought forward               3,165             2,307
 
 Profit Available for appropriations             6,631             5,614
 
 Appropriations
 
 Dividend (inclusive of dividend tax)              964               936
 
 Transfer to General Reserve                     1,500             1,500
 
 Transfer to Debenture Redemption Reserve          485                13
 
 Amount charged off in accordance with             539                 -
 transitional provisions of the Companies
 Act, 2013
 
 Balance carried forward to Balance sheet        3,143             3,165
 
 Results of Operations
 
 During the year under review, the income from operations of the Company
 increased to Rs.  45,928 million compared to Rs.  38,616 million in the
 previous year, registering an impressive growth of 19%. The profit
 after tax for the year increased by 5% to Rs.  3,466 million compared
 to Rs.  3,307 million in the previous year.
 
 During the year under review, the consolidated gross revenue of the
 Company increased to Rs.  51,785 million compared to Rs.  43,842
 million in the previous year, registering an impressive growth of 18%.
 Net profit after minority interest for the group increased to Rs.
 3,399 million from Rs.  3,168 million representing a growth of 7%.
 
 Consolidated Financial Statements
 
 In accordance with the Companies Act, 2013 (the Act) and Accounting
 Standard (AS)-21 on Consolidated Financial Statements read with AS-23
 on Accounting for Investments in Associates and AS-27 on Financial
 Reporting of Interests in Subsidiaries, Associates and Joint Ventures,
 the audited consolidated financial statements form part of the Annual
 Report.
 
 In terms of provison to sub section (3) of Section 129 of the Act, the
 salient features of the financial statements of the Subsidiaries,
 Associates and Joint Venture Companies are set out in the prescribed
 Form AOC-1 which forms a part of the Annual Report.
 
 In accordance with Section 136 of the Act, the audited financial
 statements, including the consolidated financial statements of the
 Company and audited accounts of the subsidiaries are available on the
 website www.apollohospitals.com. The documents will also be available
 for inspection during business hours at the registered office of the
 Company.
 
 Dividend
 
 The Board of Directors have recommended a dividend of Rs.  5.75 per
 equity share (115% on face value of Rs. 5/- per share) on the paid-up
 equity share capital of the company for the financial year ended 31st
 March 2015 amounting to Rs.  963.76 million inclusive of tax of Rs.
 163.79 million, which if approved at the forthcoming Annual General
 Meeting on 11th August 2015, will be paid to those shareholders whose
 names appear in the Register of Members as at the closing hours of
 business on 31st July 2015. In respect of shares held in electronic
 form, the dividend will be paid on the basis of beneficial ownership
 furnished by the depositories viz., NSDL and CDSL for this purpose.
 
 The Register of Members and Share Transfer Books will remain closed
 from Saturday, 1st August 2015 to 11th August 2015 (both days
 inclusive).
 
 Transfer of Reserves
 
 Your Company proposes to transfer Rs.  1,500 million to the general
 reserves out of the amount available for appropriations. An amount of
 Rs.  3,143 million is proposed to be retained in the Profit & Loss
 Account.
 
 Credit Rating
 
 CRISIL has rated the company''s debt instruments as AA indicating a high
 degree of safety.
 
 Subsidiaries, Joint Ventures and Associate Companies
 
 At the beginning of the year, your Company had ten direct subsidiaries,
 six step down subsidiaries, seven joint ventures and three associate
 companies. As on March 31, 2015, your Company has twelve direct
 subsidiaries and five step down subsidiaries, seven joint ventures and
 three associate companies.
 
 The statement containing the summarised financial position of the
 subsidiary companies viz., Apollo Home Healthcare (India) Limited
 (formerly known as Unique Home Health Care Limited) (AHHCL), AB Medical
 Centres Limited (ABMCL), Samudra Healthcare Enterprises Limited (SHEL),
 Apollo Hospital (UK) Limited (AHUKL), Apollo Health and Lifestyle
 Limited (AHLL), Western Hospitals Corporation Pvt Limited (WHCPL),
 Total Health (TH), Apollo Nellore Hospital Limited (ANHL), Imperial
 Hospital and Research Centre Limited (IHRCL), Alliance Medicorp (India)
 Limited (Alliance), Sapien Bio Sciences Pvt Limited (SBPL), Apollo
 Rajshree Hospitals Pvt Limited (ARHL), Apollo Bangalore Cradle Limited
 (ABCL), Apollo Cosmetic Surgical Centre Pvt Limited (ACSPL), Apollo
 Sugar Clinics Limited (ASCL), Akeso Healthcare Private Limited (AKESO)
 and Nova Speciality Hospitals Limited (NOVA), pursuant to Section 129
 and Rules 5 of the Companies (Accounts) Rules, 2014, is contained in
 Form AOC - 1 which form part of the Annual Report.
 
 Apollo Home Healthcare (India) Limited (AHHCL)
 
 (Formerly known as Unique Home Health Care Limited)
 
 AHHCL, a wholly owned subsidiary of the Company provides medical and
 paramedical services including doctor''s consultation, physiotherapy
 direct to patient homes and also offers paramedical services in
 hospitals to critically ill patients. During the year AHHCL, recorded a
 revenue of Rs.  31.18 million and a net profit of 4.28 million.
 
 AB Medical Centres Limited (ABMCL)
 
 ABMCL, a wholly owned subsidiary of the Company does not have any
 commercial operations as it has leased out its infrastructure viz.,
 land, building and medical equipment to the company for running a
 hospital. For the year ended 31st March, 2015, ABMCL recorded an income
 of Rs.  6.40 million and a net profit of Rs.  4.78 million.
 
 Samudra Healthcare Enterprises Limited (SHEL)
 
 SHEL, a wholly owned subsidiary of the Company, runs a 120 bed multi
 speciality hospital at Kakinada. For the year ended 31st March, 2015,
 SHEL recorded an income of Rs.  282.92 million and a net profit of 5.29
 million.
 
 Apollo Hospital (UK) Limited (AHUKL)
 
 AHUKL is a wholly owned foreign subsidiary of the Company and has not
 yet commenced its operations.  Apollo Health and Lifestyle Limited
 (AHLL)
 
 AHLL, a wholly owned subsidiary of the Company is engaged in the
 business of providing primary healthcare facilities through a network
 of owned/franchised clinics across India offering specialist
 consultations, diagnostics, preventive health checks, telemedicine
 facilities and a 24-hour pharmacy all under one roof. For the year
 ended 31st March, 2015, AHLL recorded an income of Rs.  1,664.35
 million and a net loss of Rs.  271.61 million.
 
 Western Hospitals Corporation Private Limited (WHCPL)
 
 For the year ended 31st March 2015, WHCPL, a wholly owned subsidiary of
 the Company, recorded a net profit of Rs.  8.93 million.
 
 Total Health (TH)
 
 Total Health, a wholly owned subsidiary of the Company registered under
 Section 25 of the then Companies Act, 1956, is carrying out CSR
 activities.
 
 Apollo Nellore Hospital Limited (ANHL)
 
 ANHL has leased out its land at Nellore to the Company. ANHL recorded
 revenues of Rs.  7.42 million and a net loss of Rs.  7.78 million.
 
 Imperial Hospital and Research Centre Limited (IHRCL)
 
 IHRCL, a 90% subsidiary of the company owns a 240 bed multi-specialty
 hospital at Bengaluru. For the year ended 31st March, 2015, IHRCL
 recorded an income of Rs.  1,671.90 million and a net profit of Rs.
 46.73 million.
 
 Alliance Medicorp India Limited (Alliance)
 
 Apollo holds a 51% stake in Alliance, which is engaged in the business
 of running dialysis clinics. For the year ended 31st March, 2015,
 Alliance recorded an income of Rs.  43.13 million and a net loss of Rs.
 6.33 million.
 
 Sapien Biosciences Pvt Ltd (SBPL)
 
 SBPL, a 70% subsidiary of the company which is engaged in the business
 of bio-banking of tissues is currently in the startup stage. For the
 year ended 31st March, 2015, SBPL recorded a net loss of Rs.  13.26
 million.
 
 Apollo Rajshree Hospitals Pvt Ltd (ARHL)
 
 ARHL, a 57.66% subsidiary of the company, runs a multi speciality
 hospital at Indore. For the year ended 31st March, 2015, ARHL recorded
 an income of Rs.  139.98 million and a net loss of Rs.  96.44 million.
 
 Apollo Bangalore Cradle Limited (ABCL)
 
 ABCL, a subsidiary of Apollo Health and Lifestyle Limited, is engaged
 in the business of healthcare service.  For the year ended 31st March,
 2015 ABCL recorded an income of Rs.  226.29 million and a net loss of
 Rs.  34.90 million.
 
 Apollo Sugar Clinics Limited (ASCL)
 
 ASCL, a subsidiary of Apollo Health and Lifestyle Limited, is engaged
 in the business of healthcare services.  For the year ended 31st March,
 2015, ASCL recorded an income of Rs.  44.44 million and a net loss of
 Rs.  50.76 million.
 
 Apollo Cosmetic Surgical Centre Pvt Ltd (ACSPL)
 
 ACSPL, a subsidiary of Apollo Health and Lifestyle Limited, is engaged
 in the business of running cosmetic surgical centres. For the year
 ended 31st March, 2015, ACSPL recorded an income of Rs.  42.56 million
 and a net loss of Rs.  1.67 million.
 
 Akeso Healthcare Private Limited (AKESO)
 
 AKESO, a wholly owned subsidiary of Apollo Health and Lifestyle
 Limited, is engaged in the business of healthcare services. For the
 period of 9 months ended 31st March, 2015 it recorded an income of Rs.
 57.39 million and a net profit of Rs.  2.35 million.
 
 Nova Speciality Hospitals Private Limited (NOVA)
 
 NOVA, a wholly owned subsidiary of Apollo Health and Lifestyle Limited,
 is engaged in the business of poly clinics, diagnostic centres and day
 care surgery centres. For the year ended 31st March 2015, NOVA recorded
 an income of Rs.  217.86 million and a net loss of Rs.  108.87 million
 
 Corporate Governance
 
 The Company is committed to maintain the highest standards of corporate
 governance and adhere to the corporate governance requirements set out
 by SEBI. The report on Corporate Governance as stipulated under the
 Listing Agreement forms an integral part of this Report. The requisite
 certificate from the Auditors of the Company confirming compliance with
 the conditions of corporate governance is attached to the report on
 Corporate Governance.
 
 Management''s Discussion and Analysis Report
 
 Management''s Discussion and Analysis Report for the year under review,
 as stipulated under Clause 49 of the Listing Agreement with the Stock
 Exchanges in India, is presented in a separate section forming part of
 the Annual Report.
 
 Sexual Harassment
 
 The Company has zero tolerance for sexual harassment at the workplace
 and has adopted a policy on prevention, prohibition and redressal of
 sexual harassment at the workplace in line with the provisions of the
 Sexual Harassment of Women at Workplace (Prevention, Prohibition and
 Redressal) Act, 2013 and the rules framed thereunder. The company did
 not receive any complaints to report in the Board''s report or intimate
 to the District Officer.
 
 Vigil Mechanism / Whistle Blower Policy
 
 The Company has established a vigil mechanism for Directors and
 Employees to report their genuine concerns, the details of which are
 given in the Corporate Governance Report. The policy on Vigil Mechanism
 and Whistle Blower Policy have been posted on the website of the
 Company www.apollohospitals.com.
 
 Particulars of Loans, Guarantees and Investments
 
 Details of Loans, Guarantees and Investments covered under the
 provisions of Section 186 of the Companies Act, 2013 are given in the
 notes to the Financial Statements.
 
 Fixed Deposits
 
 During the financial year, your Company had accepted fresh deposits of
 Rs.  43.68 million. The total deposits with the Company as on 31st
 March 2015 was Rs.  339.27 million (Rs.  354.51 million as on 31st
 March 2014) which include deposits for an aggregate value of Rs.  1.49
 million (Rs.  6.41 million as on 31st March 2014) not claimed by
 depositors.
 
 Directors and other Key Managerial Personnel (KMPs)
 
 Changes in the composition of the Board of Directors and KMPs
 
 Shri. Vinayak Chatterjee was appointed as an additional director with
 effect from 2nd July 2014 and the Members at the Annual General Meeting
 held on 25th August 2014 approved his appointment as an Independent
 Director to hold office for five (5) consecutive years for a term upto
 31st March 2019, not liable to retire by rotation.
 
 Shri. Khairil Anuar Abdullah has resigned from the office of Director
 of the Company with effect from 21st January 2015 citing his inability
 to continue given his other professional commitments.
 
 The Board wishes to place on record its appreciation for his
 contributions made during his tenure as a Director of the Company.
 
 Board Composition and Independent Directors
 
 The Board consists of the Executive Chairman, four Executive Directors
 and eight Independent Directors.  Independent directors are appointed
 for a term of five years and are not liable to retire by rotation.
 
 All Independent Directors have given declarations that they meet the
 criteria of independence as laid down under Section 149(6) of the
 Companies Act, 2013 and Clause 49 of the Listing Agreement.
 
 Retirement by Rotation
 
 Pursuant to Section 161(1) of the Companies Act, 2013 Smt.Preetha
 Reddy, Director retires by rotation at the ensuing Annual General
 Meeting and being eligible offers herself for re-appointment.
 
 Re-appointment of Executive Directors
 
 The tenure of offices of the Executive Directors viz., Smt.Preetha
 Reddy as Executive Vice Chairperson, Smt.  Suneeta Reddy as Managing
 Director and Smt. Sangita Reddy as Joint Managing Director are due for
 renewal on 3rd February 2016.
 
 The Board recommends their appointments and accordingly resolutions
 seeking approval of the members for their appointments have been
 included in the Notice of the Annual General Meeting of the Company
 along with their brief profiles.
 
 Key Managerial Personnel
 
 Pursuant to the provisions of Section 203 of the Companies Act, 2013
 the appointments of Smt. Suneeta Reddy, Managing Director, Shri.
 Krishnan Akhileswaran, Chief Financial Officer and Shri. S.M. Krishnan,
 Company Secretary, were formalized as the Key Managerial Personnel of
 the Company.
 
 Statutory Auditors and Secretarial Auditors Report
 
 The Directors hereby confirm that there is no qualification,
 reservation or adverse remark made by the statutory auditors of the
 company or in the secretarial audit report by the practicing company
 secretary for the year ended 31st March, 2015.
 
 Board Evaluation
 
 Pursuant to the provisions of the Companies Act, 2013 and Clause 49 of
 the Listing Agreement, the Board has carried out an annual performance
 evaluation of its own performance, the directors individually as well
 as the evaluation of the working of the Audit and Nomination &
 Remuneration Committees. The manner in which the evaluation has been
 carried out is stated in the Corporate Governance Report.
 
 Remuneration Policy
 
 The Board has, on the recommendation of the Nomination & Remuneration
 Committee approved a policy for selection and appointment of Directors,
 Senior Management and for determining their remuneration. The
 Remuneration Policy is stated in the Corporate Governance Report.
 
 Meetings of the Board
 
 The Board met seven times during the financial year, the details of
 which are given in the Corporate Governance Report.
 
 The intervening gap between the Meetings was within the period
 prescribed under the Companies Act, 2013.
 
 Risk Management
 
 Pursuant to the requirement of Clause 49 of the Listing Agreement, the
 Company has constituted a Business Risk Management Committee. The
 details of the Committee and its terms of reference are set out in the
 Corporate Governance Report.
 
 The Company has a robust Business Risk Management framework to
 identify, evaluate business risks and opportunities. This framework
 seeks to create transparency, minimize adverse impact on the business
 objectives and enhance the Company''s competitive advantage.
 
 The business risk framework defines the risk management approach across
 the enterprise at various levels including documentation and reporting.
 The framework has different risk models which help in identifying risk
 trends, exposure and potential impact analysis at a Company level as
 also separately for individual business segments.
 
 Internal Control Systems and their Adequacy
 
 The Company has an Internal Control System, commensurate with the size,
 scale and complexity of its operations.  To maintain its objectivity
 and independence, the Internal Audit function reports to the Chairman
 of the Audit Committee of the Board. During the year, such controls
 were tested and no reportable material weaknesses in the design or
 operation were observed.
 
 Significant and Material Orders passed by the Regulators or Courts.
 
 There are no significant material orders passed by the Regulators /
 Courts which would impact the going concern status of the Company and
 its future operations.
 
 Directors'' Responsibility Statement
 
 Pursuant to Section 134(3)(c) of the Companies Act 2013, the Directors
 of the Company hereby state and confirm:
 
 a.  that in the preparation of the annual financial statements for the
 year ended March 31,2015, the applicable accounting standards have been
 followed along with proper explanations relating to material
 departures, if any;
 
 b.  t hat such accounting policies have been selected and applied
 consistently and judgement and estimates have been made that are
 reasonable and prudent so as to give a true and fair view of the state
 of affairs of the Company as at March 31,2015 and of the profit of the
 Company for the year ended on that date;
 
 c.  t hat proper and sufficient care has been taken for the maintenance
 of adequate accounting records in accordance with the provisions of the
 Companies Act, 2013 for safeguarding the assets of the Company and for
 preventing and detecting fraud and other irregularities;
 
 d.  that the annual financial statements have been prepared on a going
 concern basis;
 
 e.  that proper internal financial controls were in place and that the
 financial controls were adequate and were operating effectively.
 
 f.  that systems to ensure compliance with the provisions of all
 applicable laws were in place and were adequate and operating
 effectively.
 
 Share Capital
 
 The paid up Equity Share Capital as on March 31,2015 was Rs.  695.63
 million. During the year under review, the Company has not issued
 shares with differential voting rights nor granted stock options nor
 sweat equity. As on March 31, 2015, the details of the shareholding by
 the Directors of the Company are set out in the Corporate Governance
 Report forming part of the Board''s Report and none of the directors
 hold convertible instruments of the Company.
 
 Rights Issue
 
 The Board at its meeting held on 28th May, 2015 approved the proposal
 to undertake an issue of equity shares to the existing shareholders on
 a Rights basis of a sum of upto Rs.  7,500 million. The purpose of the
 Rights Issue would be to provide headroom for future debt funding
 during a period of low interest rate regime as the Company continues on
 its growth path, apart from rewarding its shareholders.
 
 The Board has since constituted a Sub Committee to administer and
 oversee all matters relating to the terms of the Rights Issue.
 
 Contracts and Arrangements with Related Parties
 
 All contracts / arrangements / transactions entered by the Company
 during the financial year with related parties were in the ordinary
 course of business and on an arm''s length basis. During the year, the
 Company had not entered into any contract / arrangement / transaction
 with related parties which could be considered material in accordance
 with the policy of the Company on materiality of related party
 transactions.
 
 The Policy on materiality of related party transactions and dealing
 with related party transactions as approved by the Board may be
 accessed on the Company''s website at the link:
 http://www.apollohospitals.com . Your Directors draw attention of the
 members to the Notes to the financial statement which sets out related
 party disclosures.
 
 None of the Directors have any pecuniary relationships or transactions
 vis-a-vis the Company.
 
 Particulars of Employees and related disclosures
 
 In terms of the provisions of Section 197(12) of the Companies Act,
 2013 read with Rules 5(2) and 5(3) of the Companies (Appointment and
 Remuneration of Managerial Personnel) Rules, 2014, a statement showing
 the names and other particulars of the employees drawing remuneration
 in excess of the limits set out in the said rules is provided in the
 Annual Report.
 
 Disclosures pertaining to remuneration and other details as required
 under Section 197(12) of the Companies Act, 2013 read with Rule 5(1) of
 the Companies (Appointment and Remuneration of Managerial Personnel)
 Rules, 2014 are provided in the Annual Report.
 
 Having regard to the provisions of Section 136(1) read with its
 relevant provisio of the Companies Act, 2013, the Annual Report
 excluding the aforesaid information is being sent to the members of the
 Company. The said information is available for inspection at the
 Registered Office of the Company during working hours and any member
 interested in obtaining such information may write to the Company
 Secretary and the same will be furnished free of cost.
 
 Employee Stock Options
 
 No Employee Stock Options have been given to the employees of the
 company and thus no disclosure is required.
 
 Corporate Social Responsibility Initiatives
 
 As part of its initiatives under Corporate Social Responsibility
 (CSR), the Company has undertaken projects in the areas of Rural
 Development, Education and Health. These projects are in accordance
 with Schedule VII of the Companies Act, 2013. The Report on CSR
 activities for the financial year 2014-15 is annexed herewith as
 Annexure A.
 
 Statutory Auditors
 
 The Statutory Auditors, M/s. S. Viswanathan, Chartered Accountants,
 retire at the ensuing Annual General Meeting and have confirmed their
 eligibility and willingness to accept office, if reappointed.
 
 The Audit Committee and the Board recommend the re-appointment of
 M/s.S.Viswanathan, Chartered Accountants, as Auditors of the Company,
 to hold office till the conclusion of the next Annual General Meeting.
 
 Cost Auditors
 
 Pursuant to Section 148 of the Companies Act, 2013 read with The
 Companies (Cost Records Activities and Audit) Amendment Rules, 2014,
 your Directors had, on the recommendation of the Audit Committee,
 appointed M/s. Raman & Associates, Cost Accountants, Chennai (ICWA
 Registration No.000050) to audit the cost records of the Company for
 the financial year 2015-16 on a remuneration of Rs.  1.50 million.
 
 As required under the Companies Act, 2013, the remuneration payable to
 the cost auditor is required to be placed before the Members in a
 general meeting for their ratification. Accordingly, a resolution
 seeking Members'' ratification for the remuneration payable to M/s.
 Raman & Associates, Cost Accountants, Chennai (ICWA Registration
 No.000050) is included at Item No. 8 of the Notice convening the Annual
 General Meeting.
 
 Secretarial Audit
 
 The Board has appointed Smt. Lakshmmi Subramanian, Senior Partner, M/s.
 Lakshmmi Subramanian & Associates, a firm of Company Secretaries in
 practice, to conduct Secretarial Audit for the financial year 2014- 15.
 The Secretarial Audit Report for the financial year ended March 31,2015
 is annexed herewith as Annexure B to this Report. The Secretarial
 Audit Report does not contain any qualification, reservation or adverse
 remark.
 
 Particulars regarding Conservation of Energy, Technology Absorption and
 Foreign Exchange Earnings and Outgo
 
 The information as required to be disclosed on conservation of energy,
 technology absorption and foreign exchange earnings and outgo
 stipulated under Section 134(3)(m) of the Companies Act, 2013 read with
 Rule 8 of the Companies (Accounts) Rules, 2014, is annexed herewith as
 Annexure C.
 
 Extract of Annual Return
 
 The details forming part of the extract of the Annual Return in Form
 MGT-9 is annexed herewith as Annexure D.
 
 Acknowledgement
 
 Your Directors wish to place on record their appreciation of the
 contributions made by employees at all levels,towards the continued
 growth and prosperity of your Company.
 
 Your Directors also wish to place on record their appreciation of
 business constituents, banks and other financial institutions and
 shareholders, of the Company for their continued support.
 
 
                             For and on behalf of the Board of Directors
 
 
 Place : Chennai                                     Dr. Prathap C Reddy
 Date : 28th May, 2015                                Executive Chairman
 
 
 
 
Source : Dion Global Solutions Limited
Quick Links for apollohospitalsenterprises
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.